Induction, or preoperative therapy for octal carcinoma, is a controver
sial topic which appears to have clinical utility in a number of disti
nct settings that range from early stage to locally advanced disease.
Common to all treatment scenarios is the intent of reducing the likeli
hood of recurrence in the pelvis following surgery. An additional and
evolving role is a reduction in the extent of surgery following a comp
lete or partial clinical response to the induction regimen. While radi
ation as a single modality can lead to downstaging and, perhaps, a red
uction in local recurrence, combined modality with 5-fluorouracil (5-F
U) and radiation appears to have a greater therapeutic benefit that ma
y be further enhanced by the administration of leucovorin. Semin. Surg
. Oncol. 15:120-125, 1998. (C) 1998 Wiley-Liss, Inc.